Nugenerex Immuno-oncology, Inc. Interest Payable, Current
Nugenerex Immuno-oncology, Inc. had Interest Payable, Current of $4.66 million as of 2021-04-30, per its 10-Q filed 2021-06-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2021-06-14
- 2021-04-30: Interest Payable, Current $4.66M.
- 2021-01-31: Interest Payable, Current $4.40M.
- 2020-10-31: Interest Payable, Current $4.15M.
- 2020-07-31: Interest Payable, Current $3.91M.
| Period end | Interest Payable, Current |
|---|---|
| 2021-04-30 | $4.66M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $4.40M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $4.15M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $3.91M 10-Q · filed 2021-06-14 |
| 2020-04-30 | $3.68M 10-Q · filed 2020-06-19 |
| 2020-01-31 | $3.46M 10-Q · filed 2020-06-17 |
| 2019-07-31 | $3.06M 10-K · filed 2020-10-29 |